Open access

DEVELOPING A GLOBAL CORE COMPETENCY FRAMEWORK FOR CLINICAL RESEARCH
Amélie Julé, Tamzin Furtado, Liam Boggs, François Van Loggerenberg, Trudie Lang

BMJ Global Health Feb 2017, 2 (Suppl 2) A54-A55; DOI: 10.1136/bmjgh-2016-000260.145
FUNCTIONAL COMMUNICATION IN MULTISITE, MULTILINGUAL CONSORTIUMS: EVALUATION OF THE COMMUNICATION TOOLS USED IN THE WANETAM NETWORK
Marie Thorpe, Elizabeth Batchilly, Jean-Pierre N'Guessan, Dembo Kanteh

BMJ Global Health Feb 2017, 2 (Suppl 2) A54; DOI: 10.1136/bmjgh-2016-000260.144
NEW E-LEARNING TOOL FOR FEMALE GENITAL SCHISTOSOMIASIS: A SUPPLEMENT TO THE WHO POCKET ATLAS OF FGS
Solrun Søfteland, Motshedisi Sebitloane, Bellington Vwalika, Myra Taylor, Hashini Galappaththi-Arachchige, Sigve Holmen, Svein Gunnar Gundersen, Patricia Ndhlovu, Eyrun Floerecke Kjetland

BMJ Global Health Feb 2017, 2 (Suppl 2) A55; DOI: 10.1136/bmjgh-2016-000260.146
RESEARCH ETHICS CAPACITY BUILDING FOR THE NEXT DECADE – ‘BEYOND TRAINING’ – RHINNO ETHICS AS MODEL TO IMPROVE AND ACCELERATE ETHICS REVIEW OF HEALTH RESEARCH
Francis Kombe, Jacintha Toohey, Carel Ijsselmuiden

BMJ Global Health Feb 2017, 2 (Suppl 2) A55; DOI: 10.1136/bmjgh-2016-000260.147
EBOLA AND CLINICAL TRIAL ACTIVITY ON THE AFRICAN CONTINENT
Elizabeth Pienaar, Tamara Kredo

BMJ Global Health Feb 2017, 2 (Suppl 2) A55-A56; DOI: 10.1136/bmjgh-2016-000260.148
FIELD PERFORMANCE OF POINT-OF-CARE TO DETERMINE HBSAG TEST FOR DIAGNOSIS OF ACTIVE HEPATITIS B VIRUS INFECTION IN ZAMBIA
Caroline Chisenga, Kalo Musukwa, Roma Chilengi, Samuel Zürcher, Virginia Munamunungu, Alice Siyunda, Temwani Mwandu, Sophie Bauer, Gilles Wandeler, Michael Vinikoor

BMJ Global Health Feb 2017, 2 (Suppl 2) A56-A57; DOI: 10.1136/bmjgh-2016-000260.151
THE UTILITY OF FINGERPRINT-BASED PARTICIPANT IDENTIFICATION AND CONSENTING IN CLINICAL TRIALS IN DEVELOPING COUNTRY SETTINGS
Joseph Okebe, Pa Modou Cham, Ismaela Abubakar, Bai Lamin Dondeh, Umberto D'Alessandro

BMJ Global Health Feb 2017, 2 (Suppl 2) A56; DOI: 10.1136/bmjgh-2016-000260.149
IMPROVING EFFICIENCY AND QUALITY IN CLINICAL TRIALS IN SUB-SAHARAN AFRICA
Nerina Vischer, Constanze Pfeiffer, Christian Burri

BMJ Global Health Feb 2017, 2 (Suppl 2) A56; DOI: 10.1136/bmjgh-2016-000260.150
COMMUNITY KNOWLEDGE, ATTITUDES AND PRACTICES (KAP) DURING MDA INTEGRATED MALARIA ELIMINATION AND SCHISTOSOMIASIS AND SOIL-TRANSMITTED HELMINTHS CONTROL STUDY IN NGODHE ISLAND, LAKE VICTORIA, KENYA
Peter Mwaura, James Kongere, Kevin Omolloh, Jesse Gitaka

BMJ Global Health Feb 2017, 2 (Suppl 2) A57; DOI: 10.1136/bmjgh-2016-000260.153
EVALUATION OF CIRCULATING CATHODIC ANTIGEN (CCA) URINE-CASSETTE ASSAY AS A SURVEY TOOL FOR SCHISTOSOMA MANSONI IN DIFFERENT TRANSMISSION SETTINGS WITHIN BUGIRI DISTRICT, UGANDA
Moses Adriko

BMJ Global Health Feb 2017, 2 (Suppl 2) A57; DOI: 10.1136/bmjgh-2016-000260.152

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages